Teprotumumab may have greater efficacy than IVMP in thyroid eye disease

• Posted on: May 6 2022
• By: Saratoga Opthalmology
• Leave a response

This matching-adjusted indirect comparison (MAIC) of teprotumumab vs intravenous methylprednisolone (IVMP) vs placebo assessed improvements in proptosis and diplopia in moderate-to-severe thyroid eye disease (TED).
Source: AAO

Posted in: Uncategorized